{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:41:49Z","timestamp":1785552109420,"version":"3.56.0"},"reference-count":145,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jdsjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.jdermsci.2016.10.004","type":"journal-article","created":{"date-parts":[[2016,10,15]],"date-time":"2016-10-15T10:42:11Z","timestamp":1476528131000},"page":"3-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Alopecia areata: What\u2019s new in epidemiology, pathogenesis, diagnosis, and therapeutic options?"],"prefix":"10.1016","volume":"86","author":[{"given":"Teruki","family":"Dainichi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Kabashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2016.10.004_bib0005","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/jid.2013.464","article-title":"Lifetime incidence risk of alopecia areata estimated at 2.1% by Rochester Epidemiology Project, 1990\u20132009","volume":"134","author":"Mirzoyev","year":"2014","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0010","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000444580","article-title":"Prevalence of skin and skin-related diseases in the rochester epidemiology project and a comparison with other published prevalence studies","volume":"232","author":"Andersen","year":"2016","journal-title":"Dermatology"},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0015","doi-asserted-by":"crossref","first-page":"411","DOI":"10.5021\/ad.2015.27.4.411","article-title":"Alopecia areata in the elderly: a 10-year retrospective study","volume":"27","author":"Jang","year":"2015","journal-title":"Ann. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0020","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jaad.2010.08.032","article-title":"Comorbidity profiles among patients with alopecia areata: the importance of onset age, a nationwide population-based study","volume":"65","author":"Chu","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0025","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1468-3083.2011.04152.x","article-title":"Is atopy and autoimmunity more prevalent in patients with alopecia areata? A comparative study","volume":"26","author":"Serarslan","year":"2012","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0030","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1001\/jamadermatol.2014.3324","article-title":"Association of vitiligo and alopecia areata with atopic dermatitis: a systematic review and meta-analysis","volume":"151","author":"Mohan","year":"2015","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0035","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/jidsymp.2015.44","article-title":"Prevalence of comorbid conditions and sun-induced skin cancers in patients with alopecia areata","volume":"17","author":"Miller","year":"2015","journal-title":"J. Invest. Dermatol. Symp. Proc."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0040","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1111\/jdv.13325","article-title":"Dissecting susceptibility from exogenous triggers: the model of alopecia areata and associated inflammatory skin diseases","volume":"29","author":"Garzorz","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0045","doi-asserted-by":"crossref","first-page":"11718","DOI":"10.1038\/srep11718","article-title":"Alopecia areata increases the risk of stroke: a 3-year follow-up study","volume":"5","author":"Kang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0050","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jaad.2016.02.1234","article-title":"Cardiovascular risk in patients with alopecia areata (AA): a propensity-matched retrospective analysis","volume":"75","author":"Huang","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0055","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.canep.2016.02.009","article-title":"Reduced incidence of skin cancer in patients with alopecia areata: a retrospective cohort study","volume":"41","author":"Mostaghimi","year":"2016","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0060","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Vos","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0065","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1038\/jid.2013.446","article-title":"The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions","volume":"134","author":"Hay","year":"2014","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0070","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/bjd.13559","article-title":"The global burden of disease associated with alopecia areata","volume":"172","author":"Karimkhani","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0075","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1038\/jid.2010.232","article-title":"Quality of life in alopecia areata: a study of 60 cases","volume":"130","author":"Dubois","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0080","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2340\/00015555-1031","article-title":"Psychosocial stress and coping in alopecia areata: a questionnaire survey and qualitative study among 45 patients","volume":"91","author":"Matzer","year":"2011","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0085","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2133.2011.10714.x","article-title":"Psychiatric comorbidities in patients with alopecia areata in Taiwan: a case-control study","volume":"166","author":"Chu","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0090","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1111\/jdv.12315","article-title":"Psychiatric symptomatology and health-related quality of life in children and adolescents with alopecia areata","volume":"28","author":"Bilgic","year":"2014","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0095","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1684\/ejd.2012.1752","article-title":"Development of a disease-specific instrument to measure quality of life in patients with alopecia areata","volume":"22","author":"Endo","year":"2012","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0100","doi-asserted-by":"crossref","first-page":"e276","DOI":"10.1111\/j.1468-3083.2012.04629.x","article-title":"Quality of life in alopecia areata: a disease-specific questionnaire","volume":"27","author":"Fabbrocini","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0105","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/bjd.14497","article-title":"Alopecia areata and health-related quality of life: a systematic review and meta-analysis","volume":"175","author":"Rencz","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0110","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.jaad.2016.04.035","article-title":"Health-related quality of life (HRQoL) among patients with alopecia areata (AA): a systematic review","volume":"75","author":"Liu","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jdermsci.2015.01.004","article-title":"The genetics of alopecia areata: new approaches, new findings, new treatments","volume":"78","author":"Biran","year":"2015","journal-title":"J. Dermatol. Sci"},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0120","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature09114","article-title":"Genome-wide association study in alopecia areata implicates both innate and adaptive immunity","volume":"466","author":"Petukhova","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0125","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/sj.jid.5701183","article-title":"Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack","volume":"128","author":"Ito","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0130","doi-asserted-by":"crossref","first-page":"5966","DOI":"10.1038\/ncomms6966","article-title":"Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci","volume":"6","author":"Betz","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0135","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4161\/auto.22399","article-title":"BCL2L11\/BIM: a novel molecular link between autophagy and apoptosis","volume":"9","author":"Luo","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng.728","article-title":"Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci","volume":"43","author":"Melum","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0145","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1091\/mbc.E11-12-1018","article-title":"GARP regulates the bioavailability and activation of TGFbeta","volume":"23","author":"Wang","year":"2012","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0150","doi-asserted-by":"crossref","first-page":"13439","DOI":"10.1073\/pnas.0901965106","article-title":"Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells","volume":"106","author":"Wang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0155","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.ajhg.2010.05.004","article-title":"Evolutionary and functional analysis of celiac risk loci reveals SH2B3 as a protective factor against bacterial infection","volume":"86","author":"Zhernakova","year":"2010","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0160","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/JID.2015.402","article-title":"Functional interpretation of genome-wide association study evidence in alopecia areata","volume":"136","author":"Petukhova","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0165","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/jid.2010.427","article-title":"Genetic variants in CTLA4 are strongly associated with alopecia areata","volume":"131","author":"John","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0170","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1111\/bjd.12004","article-title":"Investigation of selected cytokine genes suggests that IL2RA and the TNF\/LTA locus are risk factors for severe alopecia areata","volume":"167","author":"Redler","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0175","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1038\/jid.2012.129","article-title":"Follow-up study of the first genome-wide association scan in alopecia areata: IL13 and KIAA0350 as susceptibility loci supported with genome-wide significance","volume":"132","author":"Jagielska","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0180","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/ejhg.2011.185","article-title":"Genome-wide pooling approach identifies SPATA5 as a new susceptibility locus for alopecia areata","volume":"20","author":"Forstbauer","year":"2012","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0185","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3109\/08916934.2014.910769","article-title":"Association between TLR1 polymorphisms and alopecia areata","volume":"47","author":"Seok","year":"2014","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0190","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/jid.2014.459","article-title":"Immunochip-based analysis: high-density genotyping of immune-related loci sheds further light on the autoimmune genetic architecture of alopecia areata","volume":"135","author":"Redler","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0195","article-title":"Genome-wide analysis of copy number variants in alopecia areata in a Central European cohort reveals association with MCHR2","author":"Fischer","year":"2016","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0200","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1111\/j.1600-0625.2010.01106.x","article-title":"An unexpected twist in alopecia areata pathogenesis: are NK cells protective and CD49b+ T cells pathogenic?","volume":"19","author":"Kaufman","year":"2010","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0205","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000353159","article-title":"Comparison of interleukin-17- producing cells in different clinical types of alopecia areata","volume":"227","author":"Tojo","year":"2013","journal-title":"Dermatology"},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0210","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000350933","article-title":"Alopecia areata: infiltration of Th17 cells in the dermis, particularly around hair follicles","volume":"226","author":"Tanemura","year":"2013","journal-title":"Dermatology"},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0215","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/1346-8138.12978","article-title":"Imbalance of T-helper 17 and regulatory T cells in patients with alopecia areata","volume":"42","author":"Han","year":"2015","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0220","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/jdv.12932","article-title":"Plasmacytoid dendritic cells in alopecia areata: missing link?","volume":"30","author":"Abou Rahal","year":"2014","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0225","doi-asserted-by":"crossref","first-page":"e94260","DOI":"10.1371\/journal.pone.0094260","article-title":"Abnormal interactions between perifollicular mast cells and CD8+ T-cells may contribute to the pathogenesis of alopecia areata","volume":"9","author":"Bertolini","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0230","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1684\/ejd.2014.2380","article-title":"Involvement of FcvarepsilonR1alpha immunopositive cells in alopecia areata with atopic dermatitis and a high titer of serum immunoglobulin E","volume":"24","author":"Yoshimasu","year":"2014","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0235","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jaad.2016.03.015","article-title":"Investigation on the role of necroptosis in alopecia areata: a preliminary study","volume":"75","author":"Jang","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0240","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/jid.2012.17","article-title":"Increased expression of Cxcr3 and its ligands, Cxcl9 and Cxcl10, during the development of alopecia areata in the mouse","volume":"132","author":"McPhee","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0245","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jdermsci.2012.12.003","article-title":"CXCL10 produced from hair follicles induces Th1 and Tc1 cell infiltration in the acute phase of alopecia areata followed by sustained Tc1 accumulation in the chronic phase","volume":"69","author":"Ito","year":"2013","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0250","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jdermsci.2013.04.029","article-title":"Antihistaminic drug olopatadine downmodulates T cell chemotaxis toward CXCL10 by reducing CXCR3 expression, F-actin polymerization and calcium influx in patients with alopecia areata","volume":"72","author":"Ito","year":"2013","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0255","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1501798","article-title":"CXCR3 blockade inhibits T cell migration into the skin and prevents development of alopecia areata","author":"Dai","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0260","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jdermsci.2015.04.011","article-title":"Exploring the biology of the nail: an intriguing but less-investigated skin appendage","volume":"79","author":"Saito","year":"2015","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0265","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1038\/jid.2010.180","article-title":"Hair follicles from alopecia areata patients exhibit alterations in immune privilege-associated gene expression in advance of hair loss","volume":"130","author":"Kang","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0270","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jdermsci.2013.01.006","article-title":"Impaired inhibitory function of circulating CD4+CD25+ regulatory T cells in alopecia areata","volume":"70","author":"Shin","year":"2013","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0275","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/bjd.12396","article-title":"T-helper and regulatory T-cell cytokines in the peripheral blood of patients with active alopecia areata","volume":"169","author":"Tembhre","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0280","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/bjd.14645","article-title":"VIP, whose receptor-mediated signalling may be defective in alopecia areata, provides protection from hair follicle immune privilege collapse","volume":"175","author":"Bertolini","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0285","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4049\/jimmunol.1100657","article-title":"A mouse model of clonal CD8+ T lymphocyte-mediated alopecia areata progressing to alopecia universalis","volume":"188","author":"Alli","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0290","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1038\/jid.2015.176","article-title":"Transfer of alopecia areata to C3H\/HeJ mice using cultured lymph node-derived cells","volume":"135","author":"Wang","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0295","doi-asserted-by":"crossref","first-page":"e62935","DOI":"10.1371\/journal.pone.0062935","article-title":"Development of autoimmune hair loss disease alopecia areata is associated with cardiac dysfunction in C3H\/HeJ mice","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0300","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/jid.2012.365","article-title":"Paus R: autoimmune disease induction in a healthy human organ: a humanized mouse model of alopecia areata","volume":"133","author":"Gilhar","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0305","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1365-2133.2011.10597.x","article-title":"Demonstration of autoantibodies against tyrosine hydroxylase in patients with alopecia areata","volume":"165","author":"Kemp","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0310","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2133.2012.10889.x","article-title":"Epitopes, avidity and IgG subclasses of tyrosine hydroxylase autoantibodies in vitiligo and alopecia areata patients","volume":"167","author":"Rahoma","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0315","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1365-2133.2011.10482.x","article-title":"Increased retinol-binding protein (RBP) 4 and anti-RBP4 antibody in alopecia areata","volume":"165","author":"Ahn","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0320","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jdermsci.2013.07.014","article-title":"Birth, life, and death of the MAGE3 hypothesis of alopecia areata pathobiology","volume":"72","author":"Ito","year":"2013","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0325","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.jid.2016.04.004","article-title":"Identification of autoantigen epitopes in alopecia areata","volume":"136","author":"Wang","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0330","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/jid.2012.344","article-title":"Endogenous retinoids in the pathogenesis of alopecia areata","volume":"133","author":"Duncan","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0335","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/bjd.12980","article-title":"Vitamin D deficiency in alopecia areata","volume":"170","author":"Aksu Cerman","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0340","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/jidsymp.2015.32","article-title":"Therapy for alopecia areata in mice by stimulating the hair cycle with parathyroid hormone agonists linked to a collagen-binding domain","volume":"17","author":"Katikaneni","year":"2015","journal-title":"J. Invest. Dermatol. Symp. Proc."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0345","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1346-8138.2010.01119.x","article-title":"Trichoscopy for common hair loss diseases: algorithmic method for diagnosis","volume":"38","author":"Inui","year":"2011","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0350","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.jaad.2012.02.013","article-title":"Hair and scalp dermatoscopy","volume":"67","author":"Miteva","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0355","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jdermsci.2016.04.007","article-title":"Similarities of dermoscopic findings in alopecia areata between human and C3H\/HeJ mouse","volume":"83","author":"Suzuki","year":"2016","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0360","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1001\/jamadermatol.2014.62","article-title":"Diagnostic usefulness of a peribulbar eosinophilic infiltrate in alopecia areata","volume":"150","author":"Yoon","year":"2014","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0365","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/1346-8138.12591","article-title":"Histopathological investigation of clinically non-affected perilesional scalp in alopecias detected unexpected spread of disease activities","volume":"41","author":"Watanabe-Okada","year":"2014","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0370","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2230.2009.03523.x","article-title":"Serum T helper 1 cytokine levels are greater in patients with alopecia areata regardless of severity or atopy","volume":"35","author":"Barahmani","year":"2010","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0375","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/1346-8138.12273","article-title":"Serum thymus and activation-regulated chemokine as disease activity and response biomarker in alopecia areata","volume":"40","author":"Inui","year":"2013","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0380","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jaad.2013.05.020","article-title":"Clinical significance of serum high-mobility group box 1 level in alopecia areata","volume":"69","author":"Lee","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0385","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jdermsci.2013.08.009","article-title":"Serum granulysin as a possible key marker of the activity of alopecia areata","volume":"73","author":"Ono","year":"2014","journal-title":"J. Dermatol. Sci"},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0390","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/ced.12556","article-title":"Investigation of oxidative stress in patients with alopecia areata and its relationship with disease severity, duration, recurrence and pattern","volume":"40","author":"Yenin","year":"2015","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0395","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ebiom.2016.03.036","article-title":"Molecular signatures define alopecia areata subtypes and transcriptional biomarkers","volume":"7","author":"Jabbari","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0400","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.jaad.2012.06.006","article-title":"Multivariate analysis of prognostic factors in patients with rapidly progressive alopecia areata","volume":"67","author":"Uchiyama","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0405","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1365-2133.2012.10955.x","article-title":"British Association of Dermatologists\u2019 guidelines for the management of alopecia areata 2012","volume":"166","author":"Messenger","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0410","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jamadermatol.2013.5764","article-title":"Clobetasol propionate, 0.05%, vs hydrocortisone, 1%, for alopecia areata in children: a randomized clinical trial","volume":"150","author":"Lenane","year":"2014","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0415","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/1346-8138.12938","article-title":"Contact immunotherapy-resistant alopecia areata totalis\/universalis reactive to topical corticosteroid","volume":"42","author":"Inui","year":"2015","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0420","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4103\/0974-7753.82123","article-title":"Randomized comparison of topical betamethasone valerate foam, intralesional triamcinolone acetonide and tacrolimus ointment in management of localized alopecia areata","volume":"3","author":"Kuldeep","year":"2011","journal-title":"Int. J. Trichol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0425","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/bjd.12863","article-title":"How effective is intralesional injection of triamcinolone acetonide compared with topical treatments in inducing and maintaining hair growth in patients with alopecia areata? A critically appraised topic","volume":"170","author":"Kassim","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0430","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jaad.2015.04.049","article-title":"Benefit of different concentrations of intralesional triamcinolone acetonide in alopecia areata: an intrasubject pilot study","volume":"73","author":"Chu","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0435","first-page":"e36","article-title":"Bone mineral density in patients with alopecia areata treated with long-term intralesional corticosteroids","volume":"12","author":"Samrao","year":"2013","journal-title":"J. Drugs Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0440","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jaad.2015.09.045","article-title":"A systematic review of pulse steroid therapy for alopecia areata","volume":"74","author":"Shreberkassidim","year":"2016","journal-title":"J. Am. Acad .Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0445","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1346-8138.2010.01135.x","article-title":"Prognostic factors in methylprednisolone pulse therapy for alopecia areata","volume":"38","author":"Im","year":"2011","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0450","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/1346-8138.12637","article-title":"Detailed clinicopathological characterization of progressive alopecia areata patients treated with i.v. corticosteroid pulse therapy toward optimization of inclusion criteria","volume":"41","author":"Sato","year":"2014","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0455","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4103\/0378-6323.148608","article-title":"Intravenous methylprednisolone pulse therapy in severe alopecia areata","volume":"81","author":"Senila","year":"2015","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0460","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000341523","article-title":"Pulse corticosteroid therapy for alopecia areata: long-term outcome after 10 years","volume":"225","author":"Staumont-Salle","year":"2012","journal-title":"Dermatology"},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0465","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3109\/09546634.2013.768759","article-title":"Pulse methylprednisolone therapy for the treatment of extensive alopecia areata","volume":"25","author":"Acikgoz","year":"2014","journal-title":"J. Dermatol. Treat."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0470","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/dth.12255","article-title":"Combined oral pulse and topical corticosteroid therapy for severe alopecia areata in children: a long-term follow-up study","volume":"28","author":"Lalosevic","year":"2015","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0475","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/pde.12578","article-title":"High relapse rates despite early intervention with intravenous methylprednisolone pulse therapy for severe childhood alopecia areata","volume":"32","author":"Smith","year":"2015","journal-title":"Pediatr. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0480","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000351559","article-title":"Pulse corticosteroid therapy for alopecia areata in children: a retrospective study","volume":"227","author":"Friedland","year":"2013","journal-title":"Dermatology"},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0485","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jaad.2009.10.031","article-title":"Alopecia areata update: part II. Treatment","volume":"62","author":"Alkhalifah","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0490","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1468-3083.2011.04114.x","article-title":"Topical immunotherapy with diphenylcyclopropenone of patients with alopecia areata\u2013a large retrospective study on 142 patients with a self-controlled design","volume":"26","author":"Ohlmeier","year":"2012","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0495","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaad.2014.04.036","article-title":"Clinical efficacy of diphenylcyclopropenone in alopecia areata: retrospective data analysis of 50 patients","volume":"71","author":"Chiang","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0500","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/jidsymp.2015.28","article-title":"Clinical efficacy of diphenylcyclopropenone in alopecia areata: retrospective data analysis of 50 patients","volume":"17","author":"Chiang","year":"2015","journal-title":"J. Invest. Dermatol. Symp. Proc."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0505","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1001\/archdermatol.2012.1622","article-title":"The safety and efficacy of diphencyprone for the treatment of alopecia areata in children","volume":"148","author":"Salsberg","year":"2012","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0510","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/1346-8138.12740","article-title":"Effective squaric acid dibutylester immunotherapy is associated with a reduction of skin infiltrating T-helper (Th)1 and Th17 cells in alopecia areata patients","volume":"42","author":"Avitabile","year":"2015","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0515","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/exd.12813","article-title":"Unique microRNAs appear at different times during the course of a delayed-type hypersensitivity reaction in human skin","volume":"24","author":"Gulati","year":"2015","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0520","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jaad.2015.04.064","article-title":"Squaric acid sensitization is not required for response in the treatment of alopecia areata","volume":"73","author":"Vedak","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0525","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/j.1346-8138.2010.00942.x","article-title":"Treatment of alopecia areata with 308-nm excimer lamp","volume":"37","author":"Ohtsuki","year":"2010","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0530","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000381912","article-title":"Effectiveness of 308-nm excimer laser therapy in treating alopecia areata, determined by examining the treated sides of selected alopecic patches","volume":"231","author":"Byun","year":"2015","journal-title":"Dermatology"},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0535","doi-asserted-by":"crossref","DOI":"10.1111\/1346-8138.13419","article-title":"Three hundred and eight nanometer excimer light therapy for alopecia universalis that is resistant to other treatments: a clinical study of 11 patients","author":"Arakawa","year":"2016","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0540","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1600-0781.2011.00612.x","article-title":"Narrowband ultraviolet B phototherapy for alopecia areata","volume":"27","author":"Bayramgurler","year":"2011","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0545","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1111\/j.1468-3083.2011.04183.x","article-title":"The effect of a 1550nm fractional erbium-glass laser in female pattern hair loss","volume":"25","author":"Lee","year":"2011","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0550","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1365-2133.2011.10383.x","article-title":"Efficacy and tolerability of methotrexate in severe childhood alopecia areata","volume":"165","author":"Royer","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0555","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2340\/00015555-2173","article-title":"Methotrexate in severe childhood alopecia areata: long-term follow-up","volume":"96","author":"Lucas","year":"2016","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0560","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000339341","article-title":"Interest of high-dose pulse corticosteroid therapy combined with methotrexate for severe alopecia areata: a retrospective case series","volume":"224","author":"Droitcourt","year":"2012","journal-title":"Dermatology"},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0565","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000441250","article-title":"Efficacy and safety of methotrexate combined with low- to moderate-dose corticosteroids for severe alopecia areata","volume":"232","author":"Anuset","year":"2016","journal-title":"Dermatology"},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0570","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jaad.2015.12.055","article-title":"Treatment of recalcitrant adult alopecia areata universalis with oral azathioprine","volume":"74","author":"Vano-Galvan","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0575","article-title":"Successful hair regrowth in an acute diffuse form of alopecia areata during oral tacrolimus treatment in a patient with rheumatoid arthritis","author":"Kanameishi","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0580","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/0974-7753.179403","article-title":"Liquid nitrogen cryotherapy in recalcitrant alopecia areata: a study of 11 patients","volume":"8","author":"Zawar","year":"2016","journal-title":"Int. J. Trichol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0585","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jaad.2016.01.013","article-title":"Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study","volume":"74","author":"Papp","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0590","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.14871","article-title":"Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial","author":"Bissonnette","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0595","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jaci.2015.03.051","article-title":"The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling","volume":"136","author":"Amano","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdermsci.2016.09.007","article-title":"JAK inhibitor JTE-052 regulates contact hypersensitivity by downmodulating T cell activation and differentiation","author":"Amano","year":"2016","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0605","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.3645","article-title":"Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition","volume":"20","author":"Xing","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0610","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1038\/jid.2014.260","article-title":"Killing two birds with one stone: oral tofacitinib reverses alopecia universalis in a patient with plaque psoriasis","volume":"134","author":"Craiglow","year":"2014","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0615","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ajh.23871","article-title":"Ruxolitinib-induced reversal of alopecia universalis in a patient with essential thrombocythemia","volume":"90","author":"Pieri","year":"2015","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0620","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jaci.2014.12.1867","article-title":"Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation","volume":"135","author":"Higgins","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0625","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ebiom.2015.02.015","article-title":"Reversal of alopecia areata following treatment with the JAK1\/2 inhibitor baricitinib","volume":"2","author":"Jabbari","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0630","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jaci.2015.11.001","article-title":"Extensive alopecia areata is reversed by IL-12\/IL-23p40 cytokine antagonism","volume":"137","author":"Guttman-Yassky","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0635","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jaci.2015.06.032","article-title":"Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17\/TH22 skewing","volume":"136","author":"Suarez-Farinas","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0640","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1001\/jamadermatol.2014.1544","article-title":"Alopecia universalis successfully treated with adalimumab","volume":"150","author":"Gorcey","year":"2014","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0645","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.jaad.2014.03.005","article-title":"Alopecia areata occurring during anti-TNF therapy: a national multicenter prospective study","volume":"70","author":"Tauber","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0650","first-page":"S41","article-title":"Subcutaneous abatacept in the treatment of moderate to severe alopecia areata","volume":"135","author":"Mackay-Wiggan","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0655","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jdermsci.2014.11.009","article-title":"The PDE4 inhibitor, apremilast, suppresses experimentally induced alopecia areata in human skin in vivo","volume":"77","author":"Keren","year":"2015","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0660","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1001\/jamadermatol.2014.504","article-title":"Effects of low-dose recombinant interleukin 2 to promote T-regulatory cells in alopecia areata","volume":"150","author":"Castela","year":"2014","journal-title":"JAMA Dermatol."},{"issue":"87","key":"10.1016\/j.jdermsci.2016.10.004_bib0665","article-title":"Hair regrowth in alopecia areata patients following Stem Cell Educator therapy","volume":"13","author":"Li","year":"2015","journal-title":"BMC Med."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0670","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1073\/pnas.0536882100","article-title":"A human peripheral blood monocyte-derived subset acts as pluripotent stem cells","volume":"100","author":"Zhao","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"160","key":"10.1016\/j.jdermsci.2016.10.004_bib0675","article-title":"Targeting insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent stem cells (CB-SCs) in stem cell educator therapy: phase I\/II clinical trial","volume":"11","author":"Zhao","year":"2013","journal-title":"BMC Med."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0680","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/bjd.12397","article-title":"A randomized, double-blind, placebo- and active-controlled, half-head study to evaluate the effects of platelet-rich plasma on alopecia areata","volume":"169","author":"Trink","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0685","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jaad.2014.11.006","article-title":"Treatment of alopecia areata with simvastatin\/ezetimibe","volume":"72","author":"Lattouf","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0690","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1468-3083.2009.03543.x","article-title":"Latanoprost in the treatment of eyelash alopecia in alopecia areata universalis","volume":"24","author":"Coronel-Perez","year":"2010","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0695","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1038\/jid.2015.44","article-title":"Topical mineralocorticoid receptor blockade limits glucocorticoid-induced epidermal atrophy in human skin","volume":"135","author":"Maubec","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0700","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jdermsci.2014.08.010","article-title":"Classification of inflammatory skin diseases: a proposal based on the disorders of the three-layered defense systems, barrier, innate immunity and acquired immunity","volume":"76","author":"Dainichi","year":"2014","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0705","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jdermsci.2015.07.006","article-title":"Review of human hand microbiome research","volume":"80","author":"Edmonds-Wilson","year":"2015","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0710","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jdermsci.2014.08.012","article-title":"Human skin dendritic cells in health and disease","volume":"77","author":"Haniffa","year":"2015","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0715","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jdermsci.2016.04.011","article-title":"Allergic inflammation is augmented via histamine H4 receptor activation: the role of natural killer cells in vitro and in vivo","volume":"83","author":"Ehling","year":"2016","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0720","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nri.2015.9","article-title":"Natural killer cell memory in infection, inflammation and cancer","volume":"16","author":"Cerwenka","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jdermsci.2016.10.004_bib0725","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.immuni.2016.05.008","article-title":"Inflammasome-dependent induction of adaptive NK cell memory","volume":"44","author":"van den Boorn","year":"2016","journal-title":"Immunity"}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181116308416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181116308416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T23:24:26Z","timestamp":1718839466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181116308416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":145,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0923181116308416"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2016.10.004","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alopecia areata: What\u2019s new in epidemiology, pathogenesis, diagnosis, and therapeutic options?","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2016.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}